Amir Nashat, Director at FATE THERAPEUTICS INC (FATE), sold 160,921 shares at $22.51 ($3.6M) on 2019-07-23, disclosed to the SEC on 2019-07-25.
Open-market sale of $3.6M FATE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.51 | 411 | $9K | 0.3% |
| 2 | $22.51 | 601 | $14K | 0.4% |
| 3 | $22.51 | 1,167 | $26K | 0.7% |
| 4 | $22.51 | 59,854 | $1.3M | 37.2% |
| 5 | $22.51 | 59,854 | $1.3M | 37.2% |
| 6 | $22.51 | 132 |
| $3K |
| 0.1% |
| 7 | $22.51 | 192 | $4K | 0.1% |
| 8 | $22.51 | 374 | $8K | 0.2% |
| 9 | $22.51 | 19,168 | $431K | 11.9% |
| 10 | $22.51 | 19,168 | $431K | 11.9% |
| Total | $22.51 avg | 160,921 | $3.6M | 100% |
| Filing → |
| SRRK | BUY | 2022-06-24 | $6.2M | — | Filing → |
| MORF | SELL | 2021-05-25 | $20.4M | — | Filing → |
| MTCR | BUY | 2020-09-22 | $3.0M | — | Filing → |